
Esi sikhokelo sibonelela ngolwazi oluyimfuneko kubantu abafuna unyango lwe-papillary renal cell carcinoma (PRCC) kwindawo yabo. Siza kugubungela ukuqonda i-PRCC, sijonge iindlela zonyango, kunye nokufumana iingcaphephe ezifanelekileyo kufutshane nawe. Funda ngenkqubo yokuxilonga, unyango olukhoyo, kunye nezinto ezibalulekileyo ekufuneka uziqwalasele xa usenza izigqibo zonyango.
I-Papillary renal cell carcinoma luhlobo lomhlaza wezintso oqala kunwebu lwemibhobho yezintso. Ihlelwe ngohlobo lwe-1 kunye nohlobo lwesi-2, nganye ineempawu ezahlukileyo ezichaphazela izicwangciso zonyango. Ukufunyaniswa kwangethuba kubalulekile kwiziphumo eziyimpumelelo. Iimpawu zinokuthi zingabonakali kwaye zingabandakanya igazi kumchamo (hematuria), intlungu yecala, okanye ubunzima obucacileyo kwisisu. Ukuxilongwa ngokuqhelekileyo kubandakanya iimvavanyo ze-imaging ezifana ne-CT scans okanye i-MRI, kunye ne-biopsy ukuqinisekisa ubukho kunye nohlobo lwe-PRCC.
Unyango lwe unyango papillary renal cell carcinoma iyahluka ngokuxhomekeka kwizinto ezininzi, kubandakanywa isigaba somhlaza, impilo yonke yesigulane, kunye nohlobo lwe-PRCC (uhlobo lwe-1 okanye uhlobo lwe-2). Iindlela zonyango eziqhelekileyo ziquka:
Utyando luhlala lolona nyango luphambili lwe-PRCC yendawo. Oku kunokubandakanya i-nephrectomy engaphelelanga (ukususwa kwethumba kunye nenxalenye encinci yezintso) okanye i-nephrectomy enkulu (ukususwa kwezintso zonke). Ukhetho luxhomekeke kubukhulu kunye nendawo ye-tumor kunye nempilo yonke yesigulane. Ubuchwephesha botyando obungenelelayo obuncinci, obufana ne-laparoscopy okanye utyando oluncediswa yirobhothi, ziyanda zisetyenziswa, okukhokelela kumaxesha okuchacha ngokukhawuleza kunye nokuncipha kweengxaki.
Unyango ekujoliswe kulo ngamayeza enzelwe ukujolisa ngokukodwa kwiiseli zomhlaza ngaphandle kokonakalisa iiseli ezisempilweni. Olu nyango luhlala lusetyenziselwa i-PRCC ephezulu okanye ye-metastatic. Imizekelo ibandakanya ii-tyrosine kinase inhibitors (TKIs) ezifana ne-sunitinib, pazopanib, kunye ne-axitinib. Ukukhethwa kwonyango olujoliswe kuyo kuxhomekeke kwiimpawu ezithile zofuzo ze-tumor.
I-Immunotherapy idibanisa amajoni omzimba ukulwa neeseli zomhlaza. I-Checkpoint inhibitors, njenge-nivolumab kunye ne-pembrolizumab, isetyenziselwa ukuphatha i-PRCC ephezulu. La mayeza anceda amajoni omzimba ukuba abone kwaye ahlasele iiseli zomhlaza ngokufanelekileyo. Ukusetyenziswa kwe-immunotherapy kudla ngokukhokelwa ngama-biomarkers athile.
Unyango ngemitha lusebenzisa imitha yamandla aphezulu ukubulala iiseli zomhlaza. Inokusetyenziswa kwiimeko ezithile ukunciphisa iimpawu okanye ukulawula ukukhula kwe-PRCC, ngakumbi kwizigaba eziphambili. Ayifane isetyenziswe njengonyango lokuqala lwe-PRCC.
Ukufumana i-oncologist okanye i-urologist eqeqeshelwe umhlaza wezintso kubalulekile. Ukukhangela kwi-Intanethi, ukuthunyelwa kugqirha wakho wokhathalelo oluphambili, kunye neengcebiso ezivela kumaqela enkxaso zinokuba zizixhobo ezixabisekileyo. Qwalasela izinto ezifana namava kagqirha unyango papillary renal cell carcinoma, ukunxulumana kwabo neziko lomhlaza elaziwayo, nophononongo lwabo lwezigulane. Ungalibazisi ukwenza ishedyuli yokubonisana neengcali ezininzi ukufumana eyona ifanelekileyo kwiimfuno zakho.
Ngokhathalelo olubanzi lomhlaza, cinga ngokuqhagamshelana IZiko loPhando ngoMhlaza laseShandong Baofa. Banikezela ngeendlela zonyango eziphambili kunye neendlela ezininzi zokunakekelwa kwesigulane. Iqela labo leengcali ze-oncologists ezinamava kunye nabasebenzi benkxaso bazinikele ekuboneleleni ngezicwangciso zonyango lomntu ngamnye kubantu abajongene nazo i-papillary renal cell carcinoma.
Khumbula ukuba imeko yomntu ngamnye yahlukile. Izigqibo zonyango kufuneka zenziwe ngokubonisana nomboneleli wakho wezempilo, ngokuqwalasela iimeko zakho ezithile, isigaba kunye nohlobo lwe-PRCC, kunye nezinto ozikhethayo. Unxibelelwano oluvulekileyo neqela lakho lezonyango lubalulekile kulo lonke uhambo lwakho.
| Uhlobo loNyango | Iingenelo | Iingxaki |
|---|---|---|
| Utyando | Okunokubanako ukunyanga izifo zasekhaya, amazinga aphuculweyo okuphila | Umngcipheko weengxaki, unokungafaneleki kuzo zonke izigaba |
| Unyango ekujoliswe kulo | Isebenza kwizifo eziphambili, inetyhefu encinci kunechemotherapy | Isenokuba neziphumo ebezingalindelekanga, inokukhula ukuxhathisa ekuhambeni kwexesha |
| Immunotherapy | Ingakhokelela kwiimpendulo ezihlala ixesha elide, ngakumbi kwiimeko ezithile | Imiphumo emibi ingaba yinto ebalulekileyo, ayisebenzi kuzo zonke izigulane |
I-Disclaimer: Le ngcaciso yenzelwe iinjongo zemfundo kuphela kwaye akufanele ithathwe njengengcebiso yezonyango. Soloko udibana nengcali yokhathalelo lwempilo olufanelekileyo ukuze uxilongwe kunye nonyango lwaso nasiphi na isimo sonyango.
Iireferensi: (Bandakanya amanqaku ejenali yezonyango afanelekileyo kunye neewebhusayithi zombutho womhlaza obekekileyo apha, ezifomathiweyo njengemibhalo esemazantsi okanye ucaphulo.)
ecaleni>
umzimba>